Technology | Computed Tomography (CT) | February 15, 2017

GE Healthcare Announces FDA Clearance of GSI Xtream on Revolution CT

GSI Xtream brings volume spectral CT technology to Revolution CT

GE Healthcare, GSI Xtream, FDA clearance, spectral CT, Revolution, RSNA 2017, SCCT

February 15, 2017 — GE Healthcare announced U.S. Food and Drug Administration (FDA) 510(k) clearance of GSI Xtream on Revolution CT (computed tomography). The company also announced the first series of clinical images and first installations at Duke University Medical Center (USA), Robarts Research Institute (Canada) and The First Affiliated Hospital of Dalian Medical University (China).

GSI Xtream on Revolution CT is the first volume spectral CT technology designed to improve small lesion detection, tissue characterization and metal artifact reduction, with a simplified workflow.

From setup to post processing, GE said GSI Xtream is as intuitive as a single energy exam. GSI Assist and Clinical ID help standardize and automate protocol selection with images directly transferred to picture archiving and communication systems (PACS) and/or automated workflow (AW). These improvements, combined with native GSI reconstruction, deliver spectral CT workflow that is twice as fast compared to the Revolution HD.

Spectral CT allows clinicians to go beyond anatomy visualization to tissue characterization, allowing for differentiation between similar HU densities such as cysts and enhancing lesions. With a contrast-to-noise ratio 60 percent higher at 120 kV than single energy CT, monochromatic images improve lesion detection and enhance contrast. Bhavik Patel, M.D., assistant professor of radiology, Duke Medical Center, said “By using GSI, we may be able to characterize a lesion for diagnosis from one exam, which could generate cost savings and add value – both clinically for the patient and economically for the health system.”

GSI Xtream enhances Revolution CT’s platform with wide collimation and 50 cm field-of-view (FOV) to deliver the only volume spectral CT. Enabled by ultrafast kV switching, clinicians can scan more challenging patients and reduce the effects of motion. The Gemstone Clarity detector combined with ASiR-V delivers dose neutral exams for patients of any size.

For more information: www.gehealthcare.com

Related Content

HRS released a consensus statement on MRI for patients with cardiac implantable electronic devices
Feature | May 15, 2017
May 15, 2017 — The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement in the United States o

Physicians will need to use a CMS-certified appropriate use criteria (AUC) clinical decision support software that documents the appropriateness of an imaging order to receive full reimbursement for Medicare patients starting Jan. 1, 2018.

Feature | Cardiac Imaging| April 18, 2017 | Dave Fornell
As part of U.S. healthcare reform efforts, starting Jan.
University of California Study Searches for Consistent CT Dose Best Practices
News | Radiation Dose Management| April 17, 2017
A new study led by UC San Francisco has found that radiation doses can be safely and effectively reduced – and more...
cardiac CT showing a severe right coronary artery lesion on a Toshiba Aquillion One

A cardiac CT showing a severe right coronary artery lesion on both 3-D and curved multiplanar reconstructions from a Toshiba Aquilion One CT system. The newest generation of CT scanners have very fast gantry speeds to freeze cardiac motion, improved image quality and much lower doses than previous generation scanners from a decade ago.

Feature | CT Angiography (CTA)| April 13, 2017 | Dave Fornell
Cardiac computed tomography (CT) imaging really took off a decade ago with the introduction of 64-slice scanners, whi
Toshiba Medical Launches Aquilion Lightning CT System
News | Computed Tomography (CT)| April 12, 2017
April 12, 2017 — Providers can now offer enhanced care and safe imaging to patients with a compact and economical sol
FDA Clears Siemens Somatom go. CT platform
Technology | Computed Tomography (CT)| April 11, 2017
The U.S. Food and Drug Administration (FDA) has cleared the Somatom go. computed tomography (CT) platform from Siemens...
SCCT, Toshiba Medical, partnership, residents-in-training
News | Computed Tomography (CT)| April 05, 2017
The Society of Cardiovascular Computed Tomography (SCCT) and Toshiba Medical announced a new partnership dedicated to...
Toshiba, Aquilion One CT, model-based iterative reconstruction, MBIR, ACC 2017, FIRST, RSNA 2017
News | Computed Tomography (CT)| March 21, 2017
March 21, 2017 — Toshiba Medical demonstrated its Forward projected model-based Iterative Reconstruction SoluTion (FI
RESOLVE study, RESOLVE trial, subclinical leaflet thrombosis

A CT study from the RESOLVE Trial showing valve leaflet thrombosis on a TAVR device. The trial examined a range of surgical and transcatheter valves to show thrombosis is found across both types of devices. It also examined if anticoagulation or antiplatelet therapy could reduce thrombosis and allow a greater range of leaflet motion.

Feature | Heart Valve Technology| March 21, 2017
March 21, 2017 — About 12 percent of patients undergoing aortic valve replacement developed non-symptomatic blood clo
CTA, CT angiography, predict heart attacks, Radiology study
News | CT Angiography (CTA)| March 14, 2017
Noninvasive computed tomography (CT) angiography and stress tests can help predict which patients are likely to suffer...
Overlay Init